MYC and hepatocellular carcinoma: Given that NOP56 is a direct transcriptional target of C-myc, as previously reported (40), our data support the hypothesis that aberrant activation of C-myc in HCC leads to upregulation of NOP56, thereby driving oncogenic signaling cascades.